Intervention

Citalopram

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 35 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials35

Recruiting0

Common conditions25

Lead sponsors shown15

Clinical trials

35 shown

Antidepressant Efficacy of Psychotherapy and Citalopram in Patients With Breast Cancer and Major DepressionNCT05063604 · 2022-05-10

Improving Quality of Life in Early Parkinson's DiseaseNCT04590612 · 2021-01-01

A Comparative Study of Sage-217 Plus an Antidepressant (ADT) Versus Placebo Plus an ADT in Adults With Major Depressive DisorderNCT04476030 · 2020-11-09

Safety of Liposom With Citalopram in Elderly Patients With Major Depressive DisorderNCT04975724 · 2019-04-18

A Study in People With Depression to Test the Effects of BI 1358894 on Parts of the Brain That Are Involved in EmotionsNCT03854578 · 2019-03-12

PF-04995274 and Emotional Processing in Un-medicated DepressionNCT03516604 · 2018-05-16

Patient Stratification and Treatment Response Prediction in Neuropharmacotherapy Using Hybrid Positron Emmission Tomography/Magnetic Resconance Imaging (PET/MR)NCT02711215 · 2015-05-01

Pharmacovigilance in Gerontopsychiatric PatientsNCT02374567 · 2015-01-01

A New Treatment Approach for Major Depressive Disorder Based Upon Targeting Monoamine Oxidase A (MAO-A)NCT02269540 · 2014-10-01

Double-Blind Treatment of Major Depressive Disorder With VilazodoneNCT01742832 · 2013-05-01

The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar DepressivesNCT02028026 · 2013-04-01

Algorithm Guided Treatment Strategies for Major Depressive DisorderNCT01764867 · 2012-06-01

Brain Imaging, Genetics and Treatment for Major DepressionNCT01568684 · 2012-03-12

Safety and Efficacy of Vilazodone in Major Depressive DisorderNCT01473381 · 2011-12-01

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With DepressionNCT01436643 · 2011-11-01

Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)NCT01312922 · 2011-09-01

Optimizing Antidepressant Treatment by Genotype-dependent Adjustment of Medication According to the ABCB1 GeneNCT02237937 · 2011-09-01

Antidepressant Controlled Trial for Negative Symptoms in SchizophreniaNCT01032083 · 2011-07-01

Pilot Study to Evaluate Individualized Choice of Antidepressants in Patients With CancerNCT01725048 · 2011-01-01

Antidepressants to Promote Recovery of Cardiac Patients Suffering From DepressionNCT01099592 · 2010-11-01

Study of Treatment of Depression in Refractory AsthmaNCT01153165 · 2010-11-01

Safety and Efficacy Study of Citalopram and Lithium for the Treatment of Depressive Mood Disorder SymptomsNCT01189812 · 2010-03-01

Placebo Effects in the Treatment of Depression: Cognitive and Neural MechanismsNCT01919216 · 2010-01-01

DECIFER: Depression and Citalopram In First Episode RecoveryNCT01041274 · 2010-01-01

Seroquel Alone Versus Seroquel With an SSRI for Depression With Psychotic SymptomsNCT00955474 · 2008-09-01

Effectiveness of Methylphenidate in Improving Cognition and Function in Older Adults With DepressionNCT00602290 · 2008-02-01

Pipamperone/Citalopram (PipCit)Versus Citalopram in the Treatment of Major Depressive Disorder(MDD)NCT00672659 · 2008-02-01

Trial of Citalopram for the Prevention of DepressionNCT00317746 · 2006-11-01

Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive DisorderNCT00351910 · 2006-05-01

Effect of Add-on Citalopram to Risperidone on Negative Symptoms in SchizophreniaNCT00893256 · 2004-12-01

Effect of the Menstrual Cycle on the Symptoms of Depression and Treatment ResponseNCT00188396 · 2004-04-01

PUFA Augmentation in Treatment of Major DepressionNCT00067301 · 2003-09-01

Discontinuation Study Of Citalopram (Antidepressant) in Depressed AdolescentsNCT00249886 · 2002-09-01

CATIE-Alzheimer's Disease TrialNCT00015548 · 2001-03-01

Treating Behavioral Disturbances in Individuals With DementiaNCT00073658 · 2000-01-01

Common conditions

Leading sponsors

Massachusetts General Hospital 2 National Institute of Mental Health (NIMH) 2 PharmaNeuroBoost N.V. 2 AstraZeneca 1 Biogen 1 Boehringer Ingelheim 1 Centre for Addiction and Mental Health 1 Centre hospitalier de l'Université de Montréal (CHUM) 1 Columbia Northwest Pharmaceuticals 1 Fidia Farmaceutici s.p.a. 1 Forest Laboratories 1 Hannover Medical School 1 HolsboerMaschmeyer NeuroChemie GmbH 1 Hospital Universitari de Bellvitge 1 Imperial College London 1

Trial status mix

COMPLETED21

UNKNOWN6

TERMINATED5

WITHDRAWN3

Phase mix

PHASE414

PHASE37

PHASE25

NA4

PHASE13

EARLY_PHASE12

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.